Waaxda Caalamiga ah

Luulyo 17, Xarunta Qiimaynta Daawada (CDE) ee Maamulka Badeecadaha Caafimaadka Qaranka (NMPA) ayaa ku dhawaaqday in codsiga suuqgeynta ee Trastuzumab Deruxtecan (Enhertu®) ee daaweynta labaad ee kansarka caloosha uu si rasmi ah u aqbalay NMPA. Codsigan waa mid inte...Akhriso wax dheeraad ah»

Dhawaan, Ascentage Pharma waxay ku dhawaaqday in daawada cusub ee Bcl-2 ee lisaftoclax (APG-2575) ay ansixisay Maamulka Badeecadaha Caafimaadka Qaranka ee Shiinaha (NMPA) si loogu daweeyo bukaanada qaangaarka ah ee qaba leukemia lymphocytic ee daba-dheeraada / lymphoma-ka yar ee lymphocytic (CLL/SLL) ...Akhriso wax dheeraad ah»

Dhawaan, GenFleet Therapeutics waxay ku dhawaaqday in Xafiiska Maamulka Daawada (ISAF) ee Gobolka Maamulka Gaarka ah ee Macau ee Shiinaha uu ansixiyay Dupert® (fulzerasib, GFH925/IBI351) si loogu daaweeyo bukaanada qaba kansarka sambabka unugyada yaryar ee horumarsan (NSCLC) ee qaba KRAS G12C mutati...Akhriso wax dheeraad ah»

Bishii Juun 30, daawada Avistone ee si madax-bannaan loo sameeyay ee loo yaqaan 'MET inhibitor' Vebreltinib waxay heshay oggolaansho shuruudaysan oo ka timid Maamulka Badeecadaha Caafimaadka Qaranka (NMPA) ee Shiinaha si loogu daaweeyo bukaannada qaba kansarka sambabka ee unugyada yaryar ee aan ahayn kuwa maxalliga ah (NSCLC) ee sidda MET amplifi...Akhriso wax dheeraad ah»

Juun 30, 2025, HUTCHMED waxay ku dhawaaqday in Codsiga Daawada Cusub (NDA) ee isku-darka ORPATHYS (savolitinib) iyo TAGRISSO (osimertinib) ay ansixisay Maamulka Badeecadaha Caafimaadka Qaranka ee Shiinaha (NMPA) si loogu daaweeyo bukaannada qaba cudurka faafa ee maxalliga ah ama kuwa qaba...Akhriso wax dheeraad ah»

Juun 30, bogga rasmiga ah ee Maamulka Badeecadaha Caafimaadka Qaranka (NMPA) ayaa ku dhawaaqay in Anlotinib, oo ah daawo cusub oo heerka 1aad ah oo ay soo saartay Chia Tai Tianqing, ay heshay oggolaansho tilmaam cusub oo Shiinaha ah: daaweynta isku dhafan oo leh kiimoterabiga si loogu daaweeyo bukaanka safka hore ...Akhriso wax dheeraad ah»

Juun 26, 2025, CARsgen waxay ku dhawaaqday in Maamulka Qaranka ee Badeecadaha Caafimaadka (NMPA) ee Shiinaha uu aqbalay Codsiga Daawada Cusub (NDA) ee satriccabtagene autoleucel ("satri-cel", CT041) (musharax u taagan CAR T-cell oo ka dhan ah borotiinka Claudin18.2) si loogu daaweeyo Claudi...Akhriso wax dheeraad ah»

Juun 19, Xarunta Qiimaynta Daawada (CDE) ee Maamulka Badeecadaha Caafimaadka Qaranka (NMPA) ayaa ku dhawaaqday in duritaanka LM-108 ee Livzon Pharmaceutical la soo jeediyay si loogu daro magacaabista daaweynta degdegga ah. Isku-darka duritaanka antibody-ga monoclonal ee Kefeqibai (LM-1...Akhriso wax dheeraad ah»

Juun 19, Xarunta Qiimaynta Daawada (CDE) ee Maamulka Badeecadaha Caafimaadka Qaranka (NMPA) ayaa ku dhawaaqday in IBI343 ee Innovent Biologics loo soo jeediyay in lagu daro barnaamijka magacaabista daaweynta horumarsan, oo loogu talagalay daaweynta cudurka faafa ee maxalliga ah ama...Akhriso wax dheeraad ah»

Juun 6, joornaalka caafimaadka caalamiga ah ee Joornaalka Hematology & Oncology wuxuu daabacay natiijooyinka daraasadda wejiga I/II (KL264-01/MK-2870-001) ee TROP2 ADC sacituzumab tirumotecan (sac-TMT) oo ah daaweyn monotherapy ah oo loogu talagalay burooyinka adag ee aan la tirtiri karin ee maxalliga ah ama kuwa aan la daaweyn karin ee u adkaysta s...Akhriso wax dheeraad ah»

Juun 10, Xarunta Qiimaynta Daawada (CDE) ee Maamulka Badeecadaha Caafimaadka Qaranka (NMPA) ayaa ku dhawaaqday in Trastuzumab Deruxtecan (T-DXd, DS-8201a) la soo jeediyay in la siiyo dib u eegis mudnaan leh oo ku saabsan daaweynta bukaanada qaangaarka ah ee qaba calool xanuunka HER2-positive ee maxalliga ah ama...Akhriso wax dheeraad ah»

Dhawaan, Merck & Co., Inc. (Merck) waxay ku dhawaaqday in daawada PD-1 ee joojisa, pembrolizumab, ay ansixisay Maamulka Badeecadaha Caafimaadka Qaranka (NMPA) ee Shiinaha si loogu isticmaalo iyadoo lala kaashanayo lenvatinib iyo transarterial chemoembolization (TACE) si loogu daaweeyo bukaanada aan lahayn...Akhriso wax dheeraad ah»